FTC WILL EXAMINE AD HEALTH CLAIMS NOT APPROVED BY FDA
This article was originally published in The Tan Sheet
Executive Summary
FTC WILL EXAMINE AD HEALTH CLAIMS NOT APPROVED BY FDA to determine if the claims are "expressly qualified to convey clearly and fully the extent of the scientific support," according to an "enforcement policy statement" released by the Federal Trade Commission on May 13. The policy document is intended to promote consistency between food advertising claims regulated by FTC and food labeling claims regulated by FDA. The FTC policy applies to all food products, including dietary supplements.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning